Table 2. Prevalence of human papillomavirus among the study subjects.
| Status | Prevalence | |
|---|---|---|
| HPV positive | HPV negative | |
| Overall | ||
| Cervical cancer cases (N=185) | 154 (83.2%) | 31 (16.8%) |
| Cancer-free females (N=209) | 0 (0.0%) | 209 (100.0%) |
| Cervical cancer cases only | ||
| Stratified by age group | ||
| 20–39 years (N=25) | 22 (88.0%) | 3 (12.0%) |
| 40–59 years (N=123) | 103 (83.7%) | 20 (16.3%) |
| 60–79 years (N=37) | 29 (78.4%) | 8 (21.6%) |
| Stratified by cancer histopathology | ||
| Squamous cell carcinoma (N=125) | 100 (80.0%) | 25 (20.0%) |
| Adenocarcinoma (N=47) | 43 (91.5%) | 4 (8.5%) |
| Others (N=13) | 11 (84.6%) | 2 (15.4%) |